Bioqual (BIOQ) Stock Price, News & Analysis

Company Overview

Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer. Its services also include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides animal research model related services. Bioqual, Inc. was founded in 1981 and is based in Rockville, Maryland.

Key Stats

• Today's Range: $57.50 to $57.50
• 50-Day Range: $57.50 to $65.00
• 52-Week Range: $57.50 to $80.00
• Volume: N/A
• Average Volume: 200 shs
• Market Capitalization: $51.41 million
• P/E Ratio: N/A
• Dividend Yield: 0.87%
• Price Target: N/A
• Consensus Rating: N/A

Bioqual Stock Analysis - MarketRank™

Bioqual scored higher than 4% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Bioqual.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Bioqual is -18.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Bioqual is -18.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.02% of the float of Bioqual has been sold short.

Short Interest Ratio / Days to Cover

Bioqual has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Dividend

• Score: 0.0 / 5
• Dividend Strength: Weak

Dividend Yield

Bioqual has a dividend yield of 0.83%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Bioqual does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.02% of the float of Bioqual has been sold short.

Short Interest Ratio / Days to Cover

Bioqual has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Bioqual this week, compared to 0 articles on an average week.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Bioqual insiders have not sold or bought any company stock.

Percentage Held by Insiders

39.24% of the stock of Bioqual is held by insiders. A high percentage of insider ownership can be a sign of company health.

BIOQ Stock Analysis - Frequently Asked Questions

How have BIOQ shares performed this year?

Bioqual's stock was trading at $66.10 at the beginning of 2025. Since then, BIOQ stock has decreased by 13.0% and is now trading at $57.50.
View the best growth stocks for 2025 here.

How were Bioqual's earnings last quarter?

Bioqual, Inc. (OTCMKTS:BIOQ) released its quarterly earnings data on Tuesday, January, 21st. The company reported ($1.36) earnings per share for the quarter. Bioqual had a negative net margin of 5.54% and a negative trailing twelve-month return on equity of 7.50%.

How do I buy shares of Bioqual?

Shares of BIOQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Bioqual own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Bioqual investors own include Zymergen (ZY), Allied Gaming & Entertainment (AGAE), Align Technology (ALGN), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO) and Berkeley Energia (BKY).

Company Calendar

• Last Earnings: 1/21/2025
• Today: 3/30/2025
• Next Earnings (Estimated): 4/21/2025
• Fiscal Year End: 5/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Commercial physical research
• Sub-Industry: Business Services
• Current Symbol: OTCMKTS:BIOQ
• CIK: 719711
• Web: www.bioqual.com
• Phone: (240) 404-7654
• Fax: N/A
• Employees: 114
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($3.13)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $480,000.00
• Net Margins: -5.54%
• Pretax Margin: -8.03%
• Return on Equity: -7.50%
• Return on Assets: -4.90%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 3.73
• Quick Ratio: 3.73

Sales & Book Value

• Annual Sales: $58.59 million
• Price / Sales: 0.88
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 894,000
• Free Float: 543,000
• Market Cap: $51.41 million
• Optionable: Not Optionable
• Beta: -0.33